{"id":6512,"date":"2019-12-15T08:42:00","date_gmt":"2019-12-15T08:42:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&p=6512"},"modified":"2021-12-15T08:44:31","modified_gmt":"2021-12-15T08:44:31","slug":"guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/de\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/","title":{"rendered":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue"},"content":{"rendered":"
\n

Anand Padmanabhan<\/a>\u00a01<\/a><\/sup>,\u00a0Laura Connelly-Smith<\/a>\u00a02<\/a><\/sup>,\u00a0Nicole Aqui<\/a>\u00a03<\/a><\/sup>,\u00a0Rasheed A Balogun<\/a>\u00a04<\/a><\/sup>,\u00a0Reinhard Klingel<\/a>\u00a05<\/a><\/sup>,\u00a0Erin Meyer<\/a>\u00a06<\/a><\/sup>,\u00a0Huy P Pham<\/a>\u00a07<\/a><\/sup>,\u00a0Jennifer Schneiderman<\/a>\u00a08<\/a><\/sup>,\u00a0Volker Witt<\/a>\u00a09<\/a><\/sup>,\u00a0Yanyun Wu<\/a>\u00a010<\/a><\/sup>,\u00a0Nicole D Zantek<\/a>\u00a011<\/a><\/sup>,\u00a0Nancy M Dunbar<\/a>\u00a012<\/a><\/sup>,\u00a0Guest Editor Joseph Schwartz<\/a>\u00a013<\/a><\/sup> ,J Clin Apher. 2019 Jun;34(3):171-35<\/p>\n<\/div>\n\n

\n

The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases\/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions in fact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly summarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and\/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.<\/p>\n<\/div>\n\n

\n

https:\/\/pubmed.ncbi.nlm.nih.gov\/31180581\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

Anand Padmanabhan\u00a01,\u00a0Laura Connelly-Smith\u00a02,\u00a0Nicole Aqui\u00a03,\u00a0Rasheed A Balogun\u00a04,\u00a0Reinhard Klingel\u00a05,\u00a0Erin Meyer\u00a06,\u00a0Huy P Pham\u00a07,\u00a0Jennifer Schneiderman\u00a08,\u00a0Volker Witt\u00a09,\u00a0Yanyun Wu\u00a010,\u00a0Nicole D Zantek\u00a011,\u00a0Nancy M Dunbar\u00a012,\u00a0Guest Editor Joseph Schwartz\u00a013 ,J Clin Apher. 2019 Jun;34(3):171-35 The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis […]<\/p>\n","protected":false},"template":"","scientific_tags":[337,424],"class_list":["post-6512","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-apheresis","scientific_tags-gma"],"acf":{"sc_authors":""},"yoast_head":"\nGuidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Anand Padmanabhan\u00a01,\u00a0Laura Connelly-Smith\u00a02,\u00a0Nicole Aqui\u00a03,\u00a0Rasheed A Balogun\u00a04,\u00a0Reinhard Klingel\u00a05,\u00a0Erin Meyer\u00a06,\u00a0Huy P Pham\u00a07,\u00a0Jennifer Schneiderman\u00a08,\u00a0Volker Witt\u00a09,\u00a0Yanyun Wu\u00a010,\u00a0Nicole D Zantek\u00a011,\u00a0Nancy M Dunbar\u00a012,\u00a0Guest Editor Joseph Schwartz\u00a013 ,J Clin Apher. 2019 Jun;34(3):171-35 The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-12-15T08:44:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/\",\"name\":\"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2019-12-15T08:42:00+00:00\",\"dateModified\":\"2021-12-15T08:44:31+00:00\",\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/","og_locale":"de_DE","og_type":"article","og_title":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte","og_description":"Anand Padmanabhan\u00a01,\u00a0Laura Connelly-Smith\u00a02,\u00a0Nicole Aqui\u00a03,\u00a0Rasheed A Balogun\u00a04,\u00a0Reinhard Klingel\u00a05,\u00a0Erin Meyer\u00a06,\u00a0Huy P Pham\u00a07,\u00a0Jennifer Schneiderman\u00a08,\u00a0Volker Witt\u00a09,\u00a0Yanyun Wu\u00a010,\u00a0Nicole D Zantek\u00a011,\u00a0Nancy M Dunbar\u00a012,\u00a0Guest Editor Joseph Schwartz\u00a013 ,J Clin Apher. 2019 Jun;34(3):171-35 The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis […]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/","og_site_name":"Adacyte","article_modified_time":"2021-12-15T08:44:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/","name":"Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2019-12-15T08:42:00+00:00","dateModified":"2021-12-15T08:44:31+00:00","inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner\/6512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/media?parent=6512"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/de\/wp-json\/wp\/v2\/scientific_tags?post=6512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}